Amgen Inc. buy UBS Group AG
Start price
06.01.26
/
50%
€283.85
Target price
06.01.27
-
Performance (%)
28.23%
Price
14.08.26
€358.95
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG currently has a performance of 28.23%. A total of €5.04 was paid as dividends for this prediction. This prediction currently runs until 06.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.999% | 0.999% |
| iShares Core DAX® | 0.437% | 5.640% |
| iShares Nasdaq 100 | 1.057% | 0.282% |
| iShares Nikkei 225® | 1.769% | 0.406% |
| iShares S&P 500 | 0.368% | 1.920% |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Ratings data for AMGN provided by MarketBeat